Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Agra Ventures Ltd. (CSE: AGRA, OTCPK: AGFAF) has announced the issuance of 3,079,774 common shares at approximately $0.05 per share as part of a loan interest payment from December 2020. This action is pending final acceptance from the Canadian Securities Exchange and is subject to a four-month and one-day hold period. The company is focused on the cannabis industry, primarily through its 70% ownership of Boundary Bay Cannabis in Canada and its wholly owned subsidiary, Farmako GmbH, which aims to be a leading distributor of medical cannabis in Europe. Agra Ventures possesses a diversified asset portfolio, enhancing its position in the evolving cannabis market.
Agra Ventures Ltd. (CSE: AGRA, OTC: AGFAF) has appointed Nick Kuzyk as its permanent CEO and Director effective March 1, 2023. This decision follows Kuzyk's successful tenure as Interim CEO over the past six months. The Board expressed confidence in his ability to create value and navigate the company's opportunities in the cannabis sector. Kuzyk brings over 20 years of experience in business development and corporate finance within the cannabis industry, having previously served as Chief Strategy Officer at High Tide Inc. Agra Ventures focuses on cannabis cultivation and distribution, both in Canada and Europe.
Agra Ventures Ltd. (CSE: AGRA, OTC: AGFAF) has approved the issuance of 2,856,449 common shares at approximately $0.05 per share. This issuance is intended to cover part of the quarterly interest on a loan from December 2020. The shares will be subject to a hold period of four months and one day. Agra Ventures focuses on the international cannabis industry, with significant operations in Canada through Boundary Bay Cannabis and a presence in Europe via Farmako GmbH, which is engaged in medical cannabis distribution.